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Abstract 27 Leptospirosis is an important worldwide zoonosis. While human leptospirosis remains 28 rare in Switzerland, the incidence of canine leptospirosis is unusually high compared to 29 other European countries. The aims of this cross-sectional study were to determine the 30 exposure of asymtomatic dogs to pathogenic Leptospira in Switzerland, to characterise 31 risk factors associated seropositivity and to determine the prevalence of urinary 32 shedding. Sampling was stratified to cover the whole of Switzerland. Sera were tested 33 by the microscopic agglutination test for antibodies against a panel of 12 serovars. 34 Urine was tested for pathogenic Leptospira using a LipL32 real-time PCR. Of 377 sera, 35 55.7% (95% CI 51.2-60.7) showed a reciprocal MAT titre of ≥1:40 and 24.9% (95% CI 36 20.7-29.4) of ≥1:100 to at least one serovar. Seropositivity (MAT ≥1:100) was most 37 common to serovars Australis (14.9%; 95% CI 11.4-18.6) and Bratislava (8.8%; 95% 38 CI 6.1-11.7), followed by Copenhageni (6.1%; 95% CI 4-8.5), Canicola (5%; 95% CI 39 2.9-7.2), Grippotyphosa (4.5%; 95% CI 2.7-6.9), Pomona (4%; 95% CI 2.1-6.1), 40 Autumnalis (2.7%; 95% CI 1.1-4.5) and Icterohaemorrhagiae (1.6%; 95% CI 0.5-2.9). 41 In unvaccinated dogs (n=84) the prevalence of a MAT titre ≥100 was 17.9% (95% CI 42 10.7-27.4), with a similar distribution of reactive serovars. Variables associated with 43 seropositivity (≥1:40) to any serovar included age (OR 1.29/year (95% CI: 1.1-1.5) and 44 bioregion with higher risks in Northern Alps (OR 14.5 (95% CI 2.2-292.7), Central 45 Plateau 12.3 (95% CI 2.0-244.1) and Jura (OR 11.2 (95% CI 1.7-226.7) compared to 46 Southern Central Alps. Dogs living with horses were significantly more likely to have 47 antibodies to serovar Bratislava ((OR 4.68 (95% CI 1.2-17.2)). Hunting was a 48 significant risk factor for seropositivtiy to serovar Grippotyphosa (OR 8.03 (95% CI 1.6-49 30.8)). Urine qPCR positivity was uncommon (1/408 dogs; 0.2%; 95% CI 0-0.7). These 50 results demonstrate that dogs in Switzerland are commonly exposed to pathogenic 51 
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Leptospira; however, the risk of dogs contributing to the spread of Leptospira in the 52 environment appears low.  53  54 1. Introduction 55 Leptospirosis is a zoonotic disease with worldwide distribution affecting most 56 mammalian species (Bharti et al., 2003). It is caused by infection with pathogenic 57 Leptospira spp. The organism maintains itself in nature by colonising the renal 58 tubules of reservoir or maintenance hosts from which they are shed into the 59 environment via urine. Maintenance hosts are often rodents, but in theory any host 60 susceptible to infection can become a chronic carrier of Leptospira. Due to co-61 evolutionary adaptation, many serovars have a preference for specific maintenance 62 hosts (e.g. rats often carry serogroup Icterohaemorrhagiae) and cause very little 63 clinical signs of infection in these hosts. In contrast, if a host gets infected with a non-64 adapted serovar (incidental host infection), acute and potentially life threatening 65 disease can develop. Clinical manifestations in incidental hosts include fever, renal 66 and hepatic injury, pulmonary haemorrhage and reproductive failure (Adler, 2015). In 67 general infected maintenance hosts show leptospiruria of higher intensity and longer 68 duration compared to incidental hosts (Chernukcha et al., 1974; Rojas et al., 2010).  69 Human leptospirosis is a major public health issue in many countries, including Latin 70 America and South-East Asia, with large outbreaks linked to natural disaster and 71 flooding (Abela-Ridder et al., 2010). In developed countries of temperate zones 72 leptospirosis is considered a rare disease, with an increased occupational risk for   73 professions such as farmers, slaughterhouse workers, sewage workers and 74 veterinarians and for individuals performing outdoor activities such as fishing and 75 water sports (Picardeau, 2013).  76 
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In dogs, risk factors for acute clinical infection and exposure in asymptomatic dogs, 77 as well as associations of seropositivity with environmental or climatic factors have 78 been reported from a number of different areas of the world including Europe, North 79 and South America; Australia and New Zealand with sometimes contradicting results. 80 A recent meta-analysis identified the following major risk factors for leptospirosis: 81 male sex, mixed-breed, young dogs (<1 year), working dogs, flooding occurrence in 82 the habitat of the dog and urban environment (Azocar-Aedo and Monti, 2016). Other 83 possible risk factors are swimming, drinking from outdoor water and exposure to wild 84 animals (Ghneim et al., 2007). 85 The epidemiology of leptospirosis in Switzerland is incompletely understood. While 86 10-20% of mice, moles and shrews captured in the city of Zürich showed PCR- 87 based evidence of renal colonisation with Leptospira spp, more specific information 88 on serovars present in the environment and their relevant maintenance hosts is 89 currently not available. While the prevalence and incidence of leptospirosis in 90 humans is unknown due to low awareness of the disease and lack of an official 91 notification system, a cluster of acute leptospirosis in young, previously healthy 92 persons was recently identified in Switzerland and traced back to a surfing spot on 93 the river Reuss in canton Aargau (Schreiber et al., 2015).  94 A dramatic increase in the incidence of canine leptospirosis has been documented in 95 Switzerland between 2003 and 2012 with a peak incidence of 28/100.000 dogs in 96 canton Aargau in 2012 (Major et al., 2014). In that study over 75% of dogs, 97 presented to a veterinary university hospital developed leptospiral pulmonary 98 haemorrhage syndrome, a severe and often lethal form of leptospirosis, which has 99 previously been considered rare. In this cohort of dogs 80% showed serologic 100 evidence of infection with serovars Bratislava, belonging to serogroup Australis 101 (Major et al., 2014). The natural reservoir for members of this serogroup in 102 
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Switzerland has not yet been identified. While horses are considered an important 103 maintenance host for serovar Bratislava (Arent et al., 2015), it has been suspected 104 that this serovar can be equally carried by asymptomatic dogs thus potentially acting 105 as a source of infection for other domestic and wild animals and for humans  (Ellis, 106 2010). 107 Urinary shedding of pathogenic Leptospira has been reported in 1.5-8% of dogs not 108 suspected to have leptospirosis (Harkin et al., 2003; Rojas et al., 2010; Llewellyn et 109 al., 2016). Dog ownership has been identified as a risk factor for human leptospirosis 110 in Germany (Jansen et al., 2005), Barbados (Douglin et al., 1997) and Nicaragua 111 (Trevejo et al., 1998) suggesting transmission of Leptospira spp from dogs to 112 humans.  113 We hypothesised that there is a high level of exposure to pathogenic Leptospira in 114 dogs in Switzerland. Furthermore we hypothesised that urinary shedding of 115 leptospires is common in dogs without clinical signs of leptospirosis and that dogs 116 may therefore contribute to environmental contamination. 117 The aims of this present study were: 1) to estimate the level of exposure to 118 pathogenic Leptospira sp. by determining the prevalence of anti-leptospiral serum 119 antibodies, 2) to determine the prevalence of urinary shedding of pathogenic 120 leptospires and 3) to determine risk factors for exposure to pathogenic leptospires 121 including age, sex, breed, geographic area, vaccination status and lifestyle in dogs 122 not suspected to have leptospirosis in Switzerland. 123  124 2. Material and Methods 125 2.1. Ethical approval 126 
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Ethical approval was granted by the Federal Food Safety and Veterinary Office for 127 the study protocol (Project BE9/15). Written owner consent was obtained before 128 enrolment of dogs in the study. 129  130 2.2. Study design, recruitment, inclusion and exclusion criteria 131 The study was designed as a cross-sectional prevalence study representing the 132 whole of Switzerland. Sampling was stratified based on the number of dogs per 133 canton according to the Swiss national registry for dogs (ANIS database, Animal 134 Identity Service AG, Bern, Switzerland). The sample size was calculated to estimate 135 the true prevalence and a significant difference between two proportions assuming a 136 prevalence of 10%, test sensitivity and specificity of 95%, a power of 85% and 137 confidence levels of 0.05. The estimated prevalence was based on the 138 seroprevalence reported in previous studies using reciprocal MAT cut off titres of 139 1:10 (Arent et al., 2013; Schuller et al., 2015) and 1:100 (Davis et al., 2008; Llewellyn 140 et al., 2016).  141 Dogs were recruited at the Vetsuisse Faculty Bern and Zürich, as well as via 30 142 private practices throughout Switzerland between April and December 2015. Private 143 practices were recruited during in-house conferences at the Vetsuisse Faculty Bern 144 and Zürich. In areas with low participation, additional practices were contacted via 145 phone and invited to participate. 146 Dogs presented for routine check-ups, vaccination or problems unrelated to 147 leptospirosis were eligible for inclusion. Dogs had preferably not been vaccinated 148 against leptospirosis during the previous 16 weeks and were excluded from urine real 149 time PCR (qPCR) examination if they had received antibiotics within the past 4 150 weeks. Repeated MAT testing was advised in cases with reciprocal titres of ≥1:40 in 151 order to document titre dynamics.  152 
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 153 2.3. Sampling and Sample Handling 154 2.3.1. Stability of leptospiral DNA in canine urine with and without stabilizer 155 In preparation of the study the stability of leptospiral DNA in canine urine during 156 simulated shipping at ambient temperature with and without a stabiliser 157 (AssayAssure®; Sierra Molecular Corporation; USA) was tested. Fresh voided urine 158 from dogs without evidence of urinary tract infections as shown by absence of clinical 159 signs, normal dipstick results, inactive sediment and negative bacterial culture were 160 collected via free catch. Samples were pooled, split into 4 ml aliquots and spiked with 161 Leptospira interrogans serovar Autumnalis at 1x104/ml, 1x103 and 1x102/ml. The 162 strain L. interrogans serovar Autumnalis Akiyami was chosen due to its intermediate 163 detection limit (5 Genome equivalents per reaction) determined in a previous study 164 (Stettler, 2015). Stabiliser was added to the test group at a concentration of 1:11 165 according to the manufacturer’s instructions. The spiked samples were incubated at 166 room temperature for 4, 24 or 48 hours and then processed for DNA extraction and 167 real time PCR as described below. All spiked samples incubated for 4 and 24 hours 168 showed amplification of the target gene lipl32 regardless of the addition of stabiliser 169 and incubation time. However, after incubation of 48 hours no positive amplification 170 could be yielded without the addition of stabiliser (Suppl. Table 1). Based on these 171 positive results, the stabiliser was used for all urine samples in this study.  172  173 2.3.2. Urine samples 174 Urine samples were collected via free catch unless cystocentesis was indicated for 175 medical reasons. Four ml of urine were immediately transferred into polypropylene 176 tubes prefilled with 0.36 ml of stabiliser (ratio 1:11).  177  178 
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2.3.3. Blood samples 179 Blood was collected into tubes without anticoagulant. Blood was either sent to the 180 laboratory uncentrifuged or left to clot for 30 min before centrifugation at 2,000 x g for 181 10 minutes and subsequent serum separation. 182  183 2.3.4. Shipping and pre-analytical sample handling 184 Urine, whole blood or serum samples were shipped at ambient temperature to the 185 Department of Veterinary Bacteriology of the Vetsuisse Faculty Bern, which is the 186 national reference laboratory for animal leptospirosis in Switzerland. DNA extraction 187 was performed within 48 h of sampling. Serum and DNA extracts were either 188 immediately analyzed or frozen at -20°C until further analysis.   189  190 2.4. Questionnaire 191 Owners were encouraged to fill in a questionnaire addressing the following points: 192 age, sex, breed, neuter status, occurrence of a febrile illness in the dog or owner in 193 the past year, treatments in the past 4 weeks, life style including residential 194 environment (urban, countryside, farm, presence or absence of a garden), whether 195 the dog is mainly kept indoor or outdoor, contact to other pets, activities including 196 drinking from puddles, swimming in natural waters, hunting, walking in the woods, 197 contact with wild animal species and knowledge of confirmed cases of leptospirosis 198 in the vicinity (Supp. Figure 1). The date of last vaccination and type of vaccine were 199 either checked directly on the vaccination booklet by the veterinarian, or owners were 200 asked by phone to read aloud the vaccination record.   201  202 2.5. Microscopic agglutination testing (MAT) 203 
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Sera were examined for the presence of antibodies against pathogenic Leptospira by 204 microscopic agglutination test (MAT) according to OIE standards (Office International 205 des Epizooties OIE, 2008) at the Institute of Veterinary Bacteriology which hosts the 206 Swiss National Reference Laboratory for animal leptospirosis and is accredited by 207 the Swiss Accreditation Service (SAS) for both techniques, MAT and real-time PCR. 208 Quality management is according to DIN EN ISO/IEC 17025 with regular participation 209 in the proficiency testing schemes for serology and real-time PCR of the National 210 Serology Reference Laboratory (Australia) and Vetqas AHPA (UK).  211 For MAT testing, live cultures of twelve reference strains of Leptospira belonging to 212 10 serogroups were used in this study (Table 1). Sera were initially screened for 213 agglutination of Leptospira at a dilution of 1:25. Reactive sera were titrated in a serial 214 two-fold dilution to determine the end-point titre defined as the highest serum dilution 215 at which at least 50 % agglutination occurs. All samples were tested by the same 216 person to avoid inter-observer variability. 217  218 2.6. DNA extraction from urine and Real time PCR 219 Urine samples were centrifuged at 10 000 rpm at 4°C for 10 min. Subsequently, the 220 supernatant was discarded and the pellet resuspended in 100 µL lysis buffer 221 (containing 180 ml pyrogen-free water, 20 ml TrisHCl 1M pH 8.5, 100 µL Tween 20 222 and 48 mg Proteinase K (Sigma-Aldrich Co, St. Louis, Missouri, USA) and incubated 223 for 60 min at 60°C, followed by 15 min at 97° on an Eppendorf thermomixer comfort 224 (Vaudaux-Eppendorf AG, Basel, Switzerland). The lysates were stored at -20°C. 225 The real-time PCR targeted the gene encoding leptospiral major outer membrane 226 protein LipL32 which is only present in pathogenic Leptospira spp. Primers and probe 227 were according to (Villumsen et al., 2012) using the following primers: LipL32F (5’-228 AGA GGT CTT TAC AGA ATT TCT TTC ACT ACC T-3’), LipL32R (5’- TGG GAA 229 
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AAG CAG ACC AAC AGA-3’) and LipL32-P (5’-FAM-AAG TGA AAG GAT CTT TCG 230 TTG C-MGB-3’). The reactions were carried out on a 7500 Fast Real Time PCR 231 System (Applied Biosystems, Foster City, CA, USA) with the cycling settings 232 recommended by the manufacturer in a total reaction volume of 25 µL containing: 233 12.5 µL TaqMan® Universal PCR Master Mix, No AmpErase® UNG at a 234 concentration of 100 µM, a 1 µM concentration of each forward and reverse primer, a 235 80 nM concentration of the probe, 0.5x TaqMan® Exogenous Internal Positive 236 Control (IPC) mix, 0.5x IPC template (all reagents Applied Biosystems, Foster City, 237 CA, USA), and 2.5 µL of template. DNA from Leptospira interrogans serovar 238 Icterohaemorrhagiae strain RGA was included as a positive control and pyrogen free 239 water as a negative control.  Values above the threshold of 0.06 at cycle times <40 240 were considered positive.  241  242 2.7. Statistical analyses 243 The statistical analyses were performed using R 3.2.2 (2016, R Core Team, Vienna, 244 Austria) and IBM SPSS Statistic Version 23 for Windows.  245 The prevalence of positive urine qPCR and MAT seropositivity were calculated with a 246 confidence interval of 95%. Because of the likely interference of recent vaccination 247 with seroprevalence, subgroup analysis was performed for the group of unvaccinated 248 dogs (n=84) and the group of dogs not vaccinated within the past 16 weeks (n=255).  249 Risk factor analysis was restricted to MAT seropositivity as outcome measure 250 because only one dog tested positive on qPCR. MAT positivity was defined as 251 positive reaction to at least one serovar included in the 12 serovar panel at reciprocal 252 titres of ≥1:40 (ALL40) or ≥1:100 (ALL100). Two instead of one cut-off titres were 253 chosen in the absence of a consensus to what represents an ideal cut-off titre to 254 document exposure in a population of dogs not suspected to have leptospirosis.  255 
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In a second step MAT seropositivity was defined as seropositivity at a cut-off of off 256 ≥1:100 for the serovars Australis (AUS100), Bratislava (BRA100), Grippotyphosa 257 (GRI100), Canicola (CAN100) and Copenhageni (COP100), which were the serovars 258 that sera most commonly reacted with. Variables included in the risk factor analysis 259 are shown in Table 2.   260 For analysis of geoclimatic factors on seroprevalence, the Swiss Territory was 261 categorized into six bioregions according to a classification proposed by the Swiss 262 Federal Office for the Environment (BAFU) (Gonseth, 2001). The six regions were 263 Jura, Central Plateau, Northern Alps, Central Western Alps, Central Eastern Alps and 264 Southern Alps; each bioregion presenting similar geological, geomorphological and 265 climatic conditions (Figure 1).  266 A graphical overview of dogs included in the different steps of the analysis is shown 267 in Figure 2. Univariate analysis was performed using χ2 or Fisher's exact test for 268 categorical variables and univariate logistic regression for continuous variables. A 269 value of p ≤ 0.20 was considered as the critical level of significance for a variable to 270 be entered in a full multivariable logistic regression model. Subsequently, for each 271 outcome a manual likelihood-ratio-test backward selection of exposure variables was 272 used to determine the best fitting model and to determine independent potential risk 273 or confounding factors associated with Leptospira seropositivity. Risk factors were 274 maintained in the model at a p-value ≤ 0.05.  275 The assumption of independence of the data was potentially violated, since some 276 dogs were owned by the same owner and thus were clustered. To correct for 277 dependency, we explored extending the model by generalised estimating equations 278 (GEE) to control for clustering, by expanding the standard errors (SE) (‘robust SE’) 279 and increasing the p-values. An independence and exchangeable pattern was used 280 as correlation structure (Liang, 1986). However, the SE hardly changed and therefore 281 
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the results of unadjusted multivariable logistic regression models were reported. The 282 final models were evaluated on goodness of fit using the Hosmer-Lemeshow test. 283 Influential observations were detected using Pearson residuals, hat matrix (leverage) 284 and delta-betas (Hosmer, 2004). 285 Risk factor analysis was performed using the whole study population without 286 exclusion of vaccinal serogroups (Icterohaemorrhagiae, Canicola, Australis, 287 Grippotyphosa). To test for the potential effect of vaccination on MAT seropositivity, 288 the variable “days since vaccination” was introduced into the analysis. For 289 unvaccinated dogs a value had to be generated in order to incorporate them into the 290 model and  700 days was regarded a period after which antibodies were present due 291 to exposure to leptospires and not due to vaccination.  292  293 2.8. Mapping 294 Maps were created using QGIS 2.14 (QGIS Development Team, 2016. QGIS 295 Geographic Information System. Open Source Geospatial Foundation Project) 296  297 3. Results 298 3.1. Study population  299 The sample size to estimate a true prevalence and to identify risk factors with 300 sufficient statistical power was estimated to be 229 and 536 dogs, respectively. 301 The majority of dogs included in this study were privately owned pet dogs. Eleven 302 dogs were owned by the military, but lived in individual homes with their handlers. 21 303 dogs lived in two different rehoming kennels. Of the 377 dogs tested by serology, 304 21.1% lived in urban areas and 73.1% in rural environments including 16.9% farm 305 dogs. 306 
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Dogs originated from 20 of the 26 Swiss cantons. The geographical distribution of the 307 sampled dogs across Switzerland is shown in Figure 3.  308 The age of the dogs ranged from 4 months to 15 years (median 5 years IQR 2-9). Of 309 the 423 dogs of known breed, 341 (80.6%) were purebred from 102 different breeds 310 and 82 dogs (19.3%) were mixed-breeds. The most common breeds were Malinois 311 (8.3%), Labrador Retriever (7.8%), French Bulldogs (4%), Golden Retrievers (3.5%) 312 and Jack Russel Terrier (3.3%). The overrepresentation of Malinois dogs was due to 313 the inclusion of military dogs as well as dogs of this breed undergoing genetic 314 screening. Gender was known in 97.8% of dogs and was equally distributed with 204 315 (45.3%) female dogs (57 entire/146 neutered) and 246 (54.7%) male dogs (139 316 entire/107 neutered).  317 Of the 377 dogs tested by MAT, 373 had a known vaccination history: 43 dogs 318 (11.6%, 95% CI 40.6-50.7) were vaccinated using a bivalent vaccine including 319 serovars Canicola, and Icterohaemorrhagiae, 246 (66.3%, 95% CI 61.2-70.9) with a 320 quadrivalent vaccine including serovars Canicola, Grippotyphosa, 321 Icterohaemorrhagiae and Pomona and 84 (22.1%, 95% CI 18.1-26.4) were not 322 vaccinated. The median period between vaccination and test was 253 days (IQR 323 189.5-475.5). 324  325 3.2. Urinary shedding 326 qPCR of urine was performed for 408 dogs without clinical suspicion of leptospirosis. 327 Only one dog had a positive PCR result. This dog lived on a farm in Canton Vaud and 328 reportedly had a habit of chasing rats. The dog showed a MAT titre of 1:40 to serovar 329 Bratislava and 1:20 to serovars Australis, Canicola, Hardjo and Autumnalis. The dog 330 had been vaccinated with a bivalent anti-leptospiral vaccine 93 days before sampling. 331 
14  
In 12 dogs qPCR was repeated 2-4 weeks after initial testing because of MAT titres 332 ≥1:40 to one or several serovars. All the repeated urine samples tested negative. 333  334 3.3. Seroprevalence and Serovars  335 Due to the potential effect of vaccination on MAT seroreactivity the overall 336 seroprevalence as well as the seroreactivities to the individual serovars are shown for 337 the overall population as well as according to the vaccination status of the dogs in 338 Figure 4 A-D. While reciprocal tires of ≥1:40 and ≥1:100 were chosen as cut offs for 339 risk factor analysis, the prevalence of MAT seroreactivity was calculated for titres 340 between ≥1:20 and ≥1:3200 and are shown in Tables 3-4 and Suppl. Tables 3-4.  341  342 3.3.1. Overall population 343 Of 377 sera, 55.7% (95% CI 51-60.7) showed a reciprocal MAT titre of ≥1:40 and 344 24.9% (95% CI 20.7-39.4) of ≥1:100 to at least one serovar.  345 At ≥1:100, seropositivity was most common to serovars Australis (14.9%; CI 11.4-346 18.6) and Bratislava (8.8%; CI 6.1-11.7), folowed by Copenhageni (6.1%; CI 4-8.5), 347 Canicola (5%; CI 2.9-7.2), Grippotyphosa (4.5%; CI 2.7-6.9), Pomona (4%; CI 2.1-6.1), 348 Autumnalis (2.7%; CI 1.1-4.5) and Icterohaemorrhagiae (1.6%; CI 0.5-2.9).  349 At ≥1:40 the reactivity pattern was slighlty different with Australis, Canicola, and 350 Copenhageni being the most commonly reactive serovars, followed by Bratislava, 351 Gripotyphosa, Icterohaeorrahgiae and Pomona.  352 In order to better understand the differences in reactivity, co-reactiviy patterns were 353 also analysed (Table 5). The number of dogs with MAT reactivity to more than one 354 serogroup was higher at a cut-off titre of ≥1:40 than at a cut-off titre of ≥1:100. The 355 most common serogroup co-reactivities or double exposures at a MAT cut-off of 356 
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≥1:100 were serogroup Australis and Icterohaemorragie (40%), Australis and 357 Grippotyphosa (28.6%), Australis and Pomona (28.6%) and Canicola and 358 Icterohaemorrhagie (25.7%).  359  360 3.3.2. Dogs not vaccinated in the past 16 weeks.  361 Of 335 sera, 49% (95% CI 43.6-54) were reactive at a MAT titre of ≥1:40 and 20.6% 362 (95% CI 16.4-25.1) of ≥1:100 to at least one serovar. Seropositivtiy (MAT ≥1:100) was 363 most common to serovars Australis (11.3%; CI 8.1-14.9), Bratislava (6.9%; CI 4.2-9.6), 364 Canicola (4.5%; CI 2.4-6.9), Copenhageni (3.9%; CI 2.1-6.3), Grippotyphosa (3.6%; CI 365 1.8-5.7), Pomona (3.3%; CI 1.5-5.4), Autumnalis (2.4%; CI 0.9-4.2) and 366 Icterohaemorrhagiae (1.5%; CI 0.3-3).  367  368 3.3.3. Unvaccinated dogs.  369 In unvaccinated dogs (n=84) the overall seroprevalence was 44% (CI 33.3-54.8) at a 370 reciprocal MAT titre of ≥1:40 and 17.9% (CI 10.7-27.4) at a reciprocal MAT titre of 371 ≥1:100. The distribution of serovars was largely similar to the distribution in vaccinated 372 dogs with Australis (9.5%; CI 3.6-16.7), Bratislava (8.3%; CI 2.4-15.5) being the most 373 frequent serovars, followed by Copenhageni (3.6%; CI 0-8.3), Grippotyphosa (3.6%; CI 374 0-8.3), Canicola (3.6 CI 0-8.3), Pomona (2.4%; CI 0-0.6) and Autumnalis (2.4%; CI 0-375 6).  376  377 3.3.4. MAT titre dynamics 378 Despite the fact that in the study protocol retesting was advised in dogs with 379 reciprocal MAT titres ≥1:40,  only 11 dogs were retested after 2-3 weeks; one reason 380 being that many dogs were sampled for this study immediately prior to vaccination 381 
16  
and thus no meaningful information could be derived from repeat MAT testing due to 382 the interference of vaccinal titres. One dog showed seroconversion (BRA: 1:400 to 383 1:1600) and one dog showed persistently high titres (BRA: 1:800 to 1:1600; AUT: 384 1:1600 to 1:1600), which can be consistent with recent infection. Four dogs showed 385 decreasing titres and five dogs the same or a slightly higher titre as before.  386  387 3.4. Risk factor analysis and multivariable models 388 The prevalence of anti-leptospiral serum antibodies by sex, gender, neuter status, 389 vaccination status, region and lifestyle is reported in Suppl Table 2. 390  391 3.4.1. Univariate analysis  392 The association of 17 variables for the outcomes MAT seropositivity at titres ≥40 or 393 ≥100 to any serovar or ≥100 to individual serovars were assessed via univariate 394 analysis. The 10 variables with significant (p≤ 0.2) associations with the different 395 outcomes in the univariate analysis are shown in Table 6.  396  397 3.4.2. Multivariable analysis 398 The fitted models after backwards selection based on the likelihood ratio test are 399 displayed in Tables 7 and 8.  400 Dogs living in the bioregions Jura, Central Plateau. Northern Alps and Central 401 Eastern Alps had significantly higher odds of being seropositive for any serovar 402 compared to the bioregion Southern Alps.  403 The odds of seropositivity to any serovar significantly increased with age at both cut 404 off titres ≥1:40 and ≥1:100. The interaction between “Age” and “Days since 405 vaccination” was significant for both cut off titres, meaning that the effect of age on 406 seropositivity differed according to the amount of days between vaccination and test. 407 
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Being castrated significantly increased the odds of seropositivity against serovar 408 Australis (MAT ≥1:100). The odds of seropositivity with the serovar Bratislava (MAT≥ 409 1:100) significantly increased when the household owned a horse. 410 Hunting significantly increased the odds to be seropositive for serovar 411 Grippotyphosa. For the serovars Canicola and Copenhageni no risk factors remained 412 significant.  413 The variables that remained significant in the final logistic regression models were 414 fitted in GEE models to correct for potential dependency (clustering) in the data. 415 However, the SE hardly changed and therefore the results of unadjusted 416 multivariable logistic regression models were reported. The models showed no 417 evidence of lack of fit based on the Hosmer-Lemeshow tests and there was no strong 418 leverage. All observations were kept in the models.  419  420 4. Discussion 421 4.1. Seroprevalence  422 The results of this stratified cross-sectional study demonstrate that exposure to 423 pathogenic Leptospira is common in dogs not suspected to have leptospirosis in 424 Switzerland. Of 377 dogs tested, 24.9% showed seroreactivity to one or several 425 serovars of a 12 serovar MAT panel at a cut-off titre of ≥100 and 55.7% of dogs 426 showed reactivity at a titre of ≥40. The seroprevalence of anti-leptospiral antibodies in 427 asymptomatic dogs reported in the literature ranges between 6% in dogs in Ireland 428 using a MAT cut-off of ≥1:10  (Schuller et al., 2015), 11.4% in Greece (Burriel et al., 429 2003), 17% in dogs in southern Germany (Llewellyn et al., 2016), 17.1% in 430 Washington State, 21.5% in Poland (Krawczyk, 2005) and 49% in kenneled dogs in 431 Italy using all a cut off  ≥1:100 (Scanziani et al., 2002). In comparison, the overall 432 seroprevalence of 24.9% in Switzerland does not appear exceedingly high, especially 433 
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in view of the very high incidence of acute disease in this region in the past years. A 434 possible explanation is that albeit dogs do not seem to get more commonly exposed 435 to pathogenic Leptospira, serovars in circulation may be particularly virulent causing 436 acute and severe disease in those dogs that do get infected. Another potential 437 explanation could be that we are already seeing a change in epidemiology of canine 438 leptospirosis in Switzerland due to the introduction of new quadrivalent vaccines, by 439 the end of 2014. These vaccines contain serovars belonging to the serogroups 440 Australis and Grippotyphosa in addition to serogroups Canicola and 441 Icterohaemorrhagiae and thus potentially provide a broader spectrum of protection.  442  443 4.2. Reactive serogroups 444 Serovars Australis and Bratislava, both belonging to serogroup Australis, were 445 associated with about half of the reactive MATs, regardless of the vaccination status 446 of the dogs. These findings correlate with the fact that based on serological data, 447 members of serogroup Australis are an important cause of acute clinical infection in 448 dogs in Switzerland (Major et al., 2014). However, canine sera also reacted with a 449 broad range of other serovars including Copenhageni, Canicola, Grippotyphosa, 450 Pomona, Autumnalis and Icterohaemorrhagiae indicating that Leptospira belonging to 451 these serovars are in circulation in the environment. Studies are underway to examine 452 the role of wild animals as reservoir hosts for specific serogroups in Switzerland. 453 Serovar Bratislava has been isolated from hedgehogs in Ireland (Hathaway et al., 454 1983). As hedgehogs are frequent visitors in private gardens, and thus can come into 455 close contact with residing dogs, the role of hedgehogs as reservoir host for serovars 456 belonging to serogroup Australis in Switzerland should be further investigated.  457  458 4.3. Risk factors 459 
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In order to assess areas of increased risk, the prevalence amongst 6 different 460 biogeographic regions was compared. This bioregion classification is based on the 461 flora and fauna found in different areas of Switzerland and reflects the significant 462 climatic variations between lower Switzerland (Plateau), with low to moderate 463 altitudes (230- 960 m NN), the Jura with medium to high altitudes (360-1300 m NN), 464 the northern and southern slopes of the Alps and the high alpine areas with altitudes 465 of up to 4600 m NN (Gonseth, 2001). This classification does not take into account 466 the potentially significant regional variations in microclimate, as well as other factors 467 of importance to the transmission of Leptospira such as the presence of stagnant 468 water and the density of wildlife populations.  469 The stratification of sampling was performed independently of the bioregion 470 classification and was based on the numbers of registered dogs per canton. 471 However, the stratification naturally reflected the significant regional differences in 472 density of the canine dog population, with the highest population density in the 473 Plateau area (around 75% of the human population and more than 50% of the canine 474 population) and the lowest in the central alpine regions. As a consequence, the 475 estimates of seroprevalence in the Alpine regions of the country were based on much 476 smaller numbers than in the Plateau and Jura regions, potentially leading to a higher 477 margin of error for the lower populated areas.   478 The prevalence of anti-leptospiral serum antibodies varied significantly between 479 different bioregions. While the seroprevalence in the western high alpine regions 480 (6.7%) and the south side of the Alps (10%) was low, the seroprevalence in the 481 Northern half of the country which includes the Plateau, Jura and Northern Alps, 482 ranged between 25.2% and 28.8% and odds ratios for seropositivity in these areas 483 were high. The higher seroprevalence in bioregions with lower altitudes is biologically 484 plausible due to less extreme climatic conditions throughout the year. Periods of 485 
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extreme cold or extreme hot can be associated with reduced availability of surface 486 water and reduced seropositivity rates, because leptospires are killed by freezing or 487 desiccation (Adler, 2015). In addition to a milder climate, lower Switzerland has a 488 large number of lakes and rivers, which could facilitate indirect transmission of 489 Leptospira. However, none of the variables such as “swimming” and “drinking from 490 puddles” assessing exposure to surface water as potential risk factors for 491 seropositivity remained significant in the multivariate analysis.  492 The higher seroprevalence in this cohort of dogs not suspected to have leptospirosis 493 in the Jura and Plateau area correlates with previous studies describing the 494 geographic distribution of dogs with acute clinical infection in Switzerland with 75.5% 495 of dogs originating from the Plateau area (Major et al., 2014). A cluster of acute 496 disease in humans was recently described and could be traced back to a surfing spot 497 in canton Aargau, which is also situated in the plateau area (Schreiber et al., 2015). 498 Based on these studies, the plateau region which includes numerous lakes and rivers 499 appears to carry this highest risk of infection in Switzerland. 500 Dogs had 4.7 times higher odds of being seropositive to serovar Bratislava (MAT 501 ≥1:100) if the owner also owned a horse.  While horses can get infected with a wide 502 range of leptospiral serovars, globally, reactivity to serovar Bratislava is most 503 common and the horse is considered a maintenance host for this serovar (Ellis et al., 504 1983; Baverud et al., 2009; Adler, 2015; Arent et al., 2015). In a recent serologic 505 survey from Switzerland, 58.5% of 615 tested horses showed MAT seropositivity to at 506 least one serogroup, indicating current or recent infection. The most frequent reactive 507 serovars were Pyrogenes (22.6%), Canicola (22.1%), Australis (19.2%) and 508 Bratislava (15.9%) (Blatti et al., 2011). Horses could therefore be the source of 509 exposure for dogs to serovar Bratislava. However, serovar Bratislava has also been 510 isolated from other animals including badgers (Hathaway et al., 1983), hedgehogs, 511 
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rats and sheep (Arent et al., 2016). Therefore other factors such as spending more 512 time in nature and potentially increased contact with reservoir hosts while 513 accompanying the owner on excursions on horseback could be equally important 514 factors for dogs to get exposed to this serovar. 515 Dogs had 8 times higher odds of having a positive titre to serovar Grippotyphosa 516 (MAT ≥1:100) if they were hunting. This association may be explained by increased 517 contact to environmental sources and reservoir hosts of Leptospira and correlates 518 with the higher odds for acute leptospirosis in dogs exposed to wild animals (Ghneim 519 et al., 2007). Hunting as a risk factor for leptospirosis is also supported by human 520 data showing a high seroprevalence of leptospirosis in human hunters (Deutz et al., 521 2003a; Deutz et al., 2003b).  522 In this cohort, the odds of MAT seropositivity increased with increasing age. A 523 correlation between age and MAT seropositivity has been shown in many other 524 studies in horses (Kitson-Piggot and Prescott, 1987; Baverud et al., 2009; Blatti et al., 525 2011) and dogs (Harland et al., 2013). This relationship is plausible as infection 526 related antibodies can persist for years and the probability of having come in contact 527 with an infectious agent increases over time. 528 More difficult to explain is the fact that being castrated was a significant risk factor for 529 the seropositivity to serovar Australis (MAT ≥1:100). This finding is in contrast to 530 previous studies showing that uncastrated dogs are overrepresented in cohorts of 531 animals with acute clinical leptospirosis which lead to the hypothesis that sexually 532 intact animals manifest more often risky behaviours like sniffing around and marking 533 their territories (Ward et al., 2002; Major et al., 2014). However, due to the 534 confounding influence of vaccination on this variable, the association between neuter 535 status and seropositivity to serovar Australis should not be over interpreted.    536 
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A significant association between the living environment and seroprevalence was not 537 found in this cohort of dogs. While and increased seroprevalence was found in some 538 studies for dogs living in rural compared to urban areas (Ghneim et al. 2006), a 539 recent meta-analysis identified a higher risk in urban environments (Azocar-Aedo & 540 Monti, 2016). This is not surprising, as wildlife reservoirs can be found with high 541 density in both urban and rural environments and represent a likely source of 542 infection in both settings. Risk factors for exposure to pathogenic Leptospira 543 identified in other studies include being male or living in a kennel (Scanziani et al., 544 2002), a higher risk of infection in mixed and working breeds  (Harland et al., 2013; 545 Azocar-Aedo and Monti, 2016) as well as in dogs used to swimming and drinking 546 from outdoor sources of water (Ghneim et al., 2007). None of these risk factors was 547 confirmed in this cohort of dogs. 548  549 4.4. MAT, co-reactivities, potential confounding effects of vaccination 550 In the past the MAT has been widely used to determine previous exposure to 551 Leptospira in domestic and wild animals and in humans (Adler, 2015). With this test, 552 the presence of anti-leptospiral IgG and/or IgM is determined based on agglutination 553 of live Leptospira species after incubation with patient serum at various dilutions.  554 The MAT relies not only on inclusion of a representative panel of Leptospira spp., but 555 its interpretation also has an element of subjectivity, which can explain the significant 556 variability noted when MAT results from the same patient are compared across 557 different laboratories (Miller et al., 2011). MAT has limited sensitivity with regards to 558 the identification of the infecting serogroup in acute infection as patient IgM, which 559 predominates in early infection, has lower binding specificity than IgG (Chernukha et 560 al., 1976). The use of MAT can therefore be justified for seroprevalence studies. 561 However, cross-reactivity between different serogroups can occur leading to MAT 562 
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reactivity at lower dilutions. In the absence of a consensus of what represents an 563 ideal cut off titres for MAT positivity,  the decision was made to use two different cut 564 offs (≥1:40 and ≥1:100) to calculated seroprevalence in this present study. As 565 expected, co-reactivities were more common at lower titres in this cohort. Most 566 common co-reactivities were those between serogroups contained in the current 567 vaccines and could therefore be related to vaccination. The MAT does not 568 discriminate between vaccination titres and titres due to exposure, thus adding 569 further difficulty to the interpretation of canine tests, as a large proportion of dogs are 570 vaccinated with either bivalent or quadrivalent whole cell anti-leptospiral vaccines. 571 Despite all these limitations we decided to use MAT to estimate the seroprevalence 572 in dogs not suspected to have leptospirosis in Switzerland and to apply statistical 573 methods to minimise the effect of vaccination on prevalence results. In the absence 574 of specific data regarding antibody titres after vaccination with a quadrivalent vaccine 575 available on the European market at the time of the planning of the study, the results 576 of a study describing the dynamics of antibody titres after vaccination with anti-577 leptospiral vaccines available on the US market were used to define inclusion criteria 578 with regards to vaccination. In this study the majority of dogs developed positive MAT 579 titers immediately after vaccination, a minority of them remained seropositive by 580 week 15 (Martin et al., 2014). On the basis of these results, we decided to select 581 dogs vaccinated at least 16 weeks (112 days) before testing. Due to the multicentre 582 design of this study, this inclusion criterion was however violated in 10% of dogs. 583 Subgroup analysis between vaccinated and unvaccinated dogs, as well as dogs not 584 vaccinated in the past 112 days showed that albeit seroprevalence was slightly lower 585 if recently vaccinated dogs were excluded, there was good correlation with regards to 586 the reactive serogroups, in particular if considering the MAT titres ≥1:100.Therefore 587 the decision was made to perform risk factor analysis on the entire cohort, regardless 588 
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of vaccination status and to introduce the variable “days since vaccination” as a risk 589 factor in the model to account for the possible confounding effect of vaccination. This 590 variable only remained significant as an effect modifier for the associations between 591 age and MAT seropositivity and for the association between castration and MAT 592 seropositivity. We are therefore confident that the presented risk factors reflect risk 593 factors associated with natural infection and not vaccination.  594 In order to describe titre dynamics in dogs with MAT titres ≥1:40 follow up testing 1-2 595 weeks later was advised. However, a large proportion of dogs was tested 596 immediately prior to vaccination precluding that information of relevance to this study 597 could be retrieved from retesting. Therefore only a small proportion of dogs was 598 retested and results consistent with recent infection was found in 18% (2/11) of these 599 dogs. 600  601 4.5. Urinary shedding 602 One of the hypotheses tested in this study was that dogs contribute to the 603 maintenance and spread of pathogenic Leptospira in the environment by shedding 604 Leptospira in their urine. In that regard urine samples from 408 dogs were tested by 605 qPCR. Care was taken to preserve leptospiral DNA during shipment by use of a 606 stabiliser, which had shown to preserve leptospiral DNA for at least 48 h post 607 sampling. However, only 1/408 samples tested positive. In this dog contact to small 608 rodents was the likely source of infection however and material was insufficient for 609 molecular typing of the serovar or species level. Based on these results we 610 concluded that urinary shedding by asymptomatic dogs is uncommon. This could be 611 explained by the fact that dogs, albeit being an important incidental host for 612 serogroup Australis in Switzerland, does not appear to be an efficient maintenance 613 host for any of the locally prevalent strains, not included in the current vaccines. 614 
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However, the influence of intermittent shedding and lack of detection due to pre-615 analytical or analytical factors also need to be considered and could potentially lead 616 to a large underestimation of the actual level of renal carriage of pathogenic 617 Leptospira in the canine population (Gay et al., 2014).  618  619 5. Conclusions 620 In conclusion, the results of this study show that dogs in Switzerland are commonly 621 exposed to pathogenic Leptospira spp. with exposure being most common to serovars 622 belonging to serogroup Australis. The Swiss Jura and plateau regions carry the highest 623 risk of infection. Contact to horses and hunting were significant risk factors associated 624 with seroprositivity to serogroups Bratislava and Gripotyphosa respectively. Based on 625 our findings vaccination of dogs with quadrivalent vaccines containing serogroups 626 Australis and Gripotyphosa in addition to serogroups Icterohaemorrhagiae and 627 Canicola is advised. The risk of dogs contributing to the spread of pathogenic 628 Leptospira in the environment appears low. 629  630 Acknowledgements 631 This study was funded by the Federal Food Safety and Veterinary Office (Project 632 1.15.02). We would like to thank all veterinarians, veterinary staff and dog owners 633 who participated in the study. We would also like to thank Valentine Jaquier und 634 Isabelle Brodard for excellent technical assistance with the serological and molecular 635 analyses. This study was presented as an oral abstract at the 26th annual congress of 636 the European College of Veterinary Internal Medicine (ECVIM-CA) in Gothenburg 637 (9.9.-10.9.2016).  638 
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Tables 639  640 Table 1. Panel of 12 Leptospira spp. used as live antigens for Microscopic  641 Agglutination testing (MAT). 642  643 Genomospecies Serogroup Serovar Strain L.interrogans Australis Australis Ballico   Australis Bratislava Jez-Bratislava   Autumnalis Autumnalis Akiyami   Canicola Canicola Hond Utrecht IV   Icterohaemorrhagiae Icterohaemorrhagiae RGA   Icterohaemorrhagiae Copenhageni M20   Pomona Pomona Pomona   Pyrogenes Pyrogenes Salinem   Sejroe Hardjo Hardjoprajitno L.borgpetersenii Ballum Ballum Mus127  Tarassovi Tarassovi Perepelitsin L. kirschneri Grippotyphosa Grippotyphosa Moskva V   644 
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Table 2. Frequency of variables collected via questionnaire for dogs tested for anti-645 leptospiral serum antibodies via MAT.  646 Variable Category n % 95% CI Vaccine Not vaccinated 84 22.5% 18.2-26.5 Bivalent  43 11.5% 8.3-14.7 Quadrivalent  246 66% 61.1-71 Sex Female 170 46.1% 41.2-51.2 Male 199 53.9% 48.8-58.8 Castrated No 168 45.7% 40.6-50.7 Yes 200 54.3% 49.3-59.4 Other animals in the household No 107 31.2% 26.3-36.1 Dog 117 34.1% 29.1-39.1 Cat 59 17.2% 13.2-21.2 Dog and Cat 32 9.3% 6.3-12.4 Livestock +/-Dog/cat  5 1.5% 0.2-2.7 Horses +/- Dog/cat 23 6.7% 4.1-9.4 Bioregion Jura 51 13.5% 10.1-16.7 Central Plateau 230 61% 56.2-65.8 Northern Alps 66 17.5% 13.8-21.5 Central western Alps 15 4% 2.1-6.1 Central Eastern Alps 5 1.3% 0.3-2.7 Southern Alps 10 2.7% 1.3-4.5 Surrounding Shelter 21 5.8% 3.6-8.3 Urban 49 13.6% 10-17.2 Rural 98 27.1% 23-31.9 Farm 61 16.9% 13-20.8 Urban + Garden 27 7.5% 5-10.2 Rural + Garden 105 29.1% 24.4-33.8 Contact to acutely ill animals No 162 47.9% 42.3-53.3 Yes 28 8.3% 5.6-11.5 I do not know  148 43.8% 38.2-49.1 Previously diagnosed and treated for Leptospirosis  No 330 97.6% 95.9-99.1 Yes 8 2.4% 0.9-4.1 Fever this past year (dog)  No 305 90.2% 87-93.5 Yes 33 9.8% 6.5-13 Fever this past year (owner) No 270 81.1% 77.2-85.3 Yes 63 18.9% 14.7-22.8 Outside <50% of time 259 75.7% 71.3-80.1 >50% of time 83 24.3% 17.6-31.3 Spends time in forests No 31 9.2% 6.2-12.4 Yes 307 90.8% 87.6-93.8 Drinking from puddles No 104 30.9% 26.1-35.9 Yes 233 60.1% 64.1-73.9 Swimming  No 110 32.7% 27.7-37.8 Yes 226 67.3% 62.2-72.3 Contacts to wild animals No 190 56.2% 50.6-61.5 Yes 94 27.8% 23.4-32.5 I do not  know 54 16% 12.1-20.1 Hunting No 326 96.4% 94.4-98.2 Yes 12 3.6% 1.8-5.6 
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 Table 3.  Number of individuals, relative prev
alence and 95% C.I. per Leptospira serovar fo
r all dogs (n=377). Tested serovars: 
647 Australis (AUS), Autumnalis (AUT), Ballum
 (BAL), Bratislava (BRA), Canicola (CAN), Cope
nhageni (COP), Grippotyphosa (GRI), Hardjo 
648 (HAR), Icterohaemorrhagie (ICT), Pomon
a (POM), Pyrogenes (PYR) and Tarassovi (TAR
). 
649  650 MAT Titer  AUS BRA 
COP CAN GRI ICT POM
 PYR TAR AUT BAL 
HAR 
1:20 n 110 20 46 
75 16 27 30 14 
7 37 47 1 
% 29.2 5.3 12.2 19.9 
4.2 7.2 8 3.7 1.9
 9.8 12.5 0.3 
C.I. 24.7-33.7 3.2-8 9-15.4 15.6-24.
1 2.1-6.4 4.8-9.8 5.3-10.9 1.9-5.8 
0.5-3.4 6.9-12.7 9.3-15.9 0-0.8 
1:40 n 68 21 46 
75 26 30 22 4 
1 17 3 1 
% 18 5.6 12.2 19.9 
6.9 8 5.8 1.1 0.3
 4.5 0.8 0.3 
C.I. 14.1-22 3.2-8 9.3-15.4 15.6-24.
1 4.5-9.5 5.3-10.6 3.7-8.2 0.3-2.1 
0-0.8 2.7-6.6 0-1.9 0-0.8 
1:100 n 35 13 12 
12 8 3 9 1 
1 5 - - 
% 9.3  3.4 3.2 3.2 
2.1 0.8 2.4 0.3 0.3
 1.3 - - 
C.I. 6.6-12.2 1.9-5.6 1.6-5 1.6-5 
0.8-3.7 0-1.9 1.1-4.2 0-0.8 0-
0.8 0.3-2.7 - - 
1:200 n 12 9 8 
7 8 2 4 2 
- 2 - - 
% 3.2 2.4 2.1 1.9 
2.1 0.5 1.2 0.5 - 
0.5 - - 
C.I. 1.6-5 1.1-4.2 0.8-3.7 0.5-3.4
 0.8-3.7 0-1.3 0.3-2.1 0-1.3 
- 0-1.3 - - 
1:400 n 4 6 3 
- - 1 1 - 
- 2 - - 
% 1.1 1.6 0.8 - 
- 0.3 0.3 - - 
0.5 - - 
C.I. 0.3-2.1 0.5-2.9 0-1.9 - 
- 0-0.8 0-0.8 - - 
0-1.3 - - 
1:800 n 1 4 - 
- 1 - 1 - 
- - - - 
% 0.3 1.1 - - 
0.3 - 0.3 - - 
- - - 
C.I. 0-0.8 0.3-2.4 - - 
0-0.8 - 0-0.8 - -
 - - - 
1:1600 n 3 1 - 
- - - - - 
- 1 - - 
% 0.8 0.3 - - 
- - - - - 
0.3 - - 
C.I. 0-1.9 0-0.8 - - 
- - - - - 
0-0.8 - - 
1:3200 n 1 - - 
- - - - - 
- - - - 
% 0.3 - - - 
- - - - - 
- - - 
C.I. 0-0.8 - - - 
- - - - - 
- - - 
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 Table 4. Number of individuals, relative preva
lence and 95% C.I. per Leptospira serovar for
 unvaccinated dogs (n=84). Tested 
652 serovars: Australis (AUS), Autumnalis (AU
T), Ballum (BAL), Bratislava (BRA), Canicola (C
AN), Copenhageni (COP), Grippotyphosa 
653 (GRI), Hardjo (HAR), Icterohaemorrhagie
 (ICT), Pomona (POM), Pyrogenes (PYR) and T
arassovi (TAR). 
654  655 MAT Titer  AUS BRA C
OP CAN GRI ICT POM
 PYR TAR AUT BAL 
HAR 
1:20 n 25 2 10 
11 1 3 5 5 
3 7 9 1 
% 29.8 2.4 11.9 13.1 
1.2 3.6 6 6 3.6
 8.3 10.7 1.2 
C.I. 20.2-40.4 0-6 6-20.2 6-21.4
 0-3.6 0-8.3 1.2-11.9 1.2-11.9 
0-8.3 3.6-14.3 4.8-17.9 0-3.6 
1:40 n 9 4 6 
8 2 3 2 - 
1 5 1 - 
% 10.7 4.8 7.1 9.5 
2.4 3.6 2.4 - 1.2
 6 1.2 - 
C.I. 4.8-17.9 1.2-9.5 2.4-13.1 3.6-16.7
 0-6 0-8.3 0-6 - 
0-3.6 1.2-11.9 0-3.6 - 
1:100 n 4 2 1 
2 - - 1 - 
- - - - 
% 4.8 2.4 1.2 2.4 
- - 1.2 - - 
- - - 
C.I. 1.2-9.5 0-6 0-3.6 0-6 
- - 0-3.6 - - 
- - - 
1:200 n 4 3 2 
1 3 - - - 
- 1 - - 
% 4.8 3.6 2.4 1.2 
3.6 - - - - 
1.2 - - 
C.I. 1.2-9.5 0-8.3 0-6 0-3.6 
0-8.3 - - - -
 0-3.6 - - 
1:400 n - 1 - 
- - - 1 - 
- - - - 
% - 1.2 - - 
- - 1.2 - - 
- - - 
C.I. - 0-3.6 - - 
- - 0-3.6 - - 
- - - 
1:800 n - 1 - 
- - - - - 
- - - - 
% - 1.2 - - 
- - - - - 
- - - 
C.I. - 0-3.6 - - 
- - - - - 
- - - 
1:1600 n - - - 
- - - - - 
- 1 - - 
% - - - - 
- - - - - 
1.2 - - 
C.I. - - - - 
- - - - - 
0-3.6 - - 
 656  657 
30  
 658 Table 5. Number of individuals positive against one, two or more serogroups at a 659 MAT Titre of ≥1:40 and MAT ≥1:100. 660  661 N° of positive Serogroups MAT ≥1:40 n (%) MAT ≥1:100 n (%) 1 21 (23.1) 58 (62.4) 2 30 (33.0) 19 (20.4) 3 25 (27.5)  8 (8.6) 4 7 (7.7) 6 (6.5) 5 7 (7.7) 1 (6.5) 6 1 (1.1) 1 (1.1)   662 
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Table 6. Risk factors associated with a MAT positivity.  663  664 Variable ALL40 ALL100 AUS100 BRA100 GRI100 CAN100 COP100 Swimming *       Castrated  * **     Lives with other animals *   **  * * Hunting     **   Outside >50% of time       * Bioregion ** *      Surroundings *       Forest *       Season *       Age ** **      Days since last vaccination ** ** ** *   *  665 * Univariate analysis (p ≤ 0.2) 666 ** Multivariate analysis (p < 0.05) 667 Outcomes: Seropositivity in dogs against any of the tested serovars at MAT cut-offs 668 ≥1:40 (ALL40) and ≥1:100 (ALL100), seropositivity in dogs at the MAT cut-off ≥1:100 669 for serovars Australis (AUS100), Bratislava (BRA100), Grippotyphosa (GRI100), 670 Canicola (CAN100) and Copenhageni (COP100). 671   672 
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Table 7. Statistically significant risk factors for seropositivity against any serovar at a 673 MAT cut-off ≥ 1:40 tested in a multivariable logistic regression model. 674  Covariate Levels Odds ratio 95% CI p-value Bioregion 6# Ref.    1 11.17 1.69-226.72 0.034*  2 12.43 2.04-244.12 0.023*  3 14.51 2.23-292.71 0.018*  4 5.53 0.63-125.11 0.17  5 53.05 3.39-2378.75 0.012* Age (years)  1.29 1.13-1.47 0.0001* Days since vaccination  1.0008 0.9988-1.0028 0.42 Days since vaccination*Age  0.9995 0.9992-0.9998 0.0034*  675 * Statistically significant at p < 0.05, AIC full model = 408.25 & n=301, AIC final model 676 = 458.49 & n=347. 677 # The numbers correspond with the bioregions (1) Jura, (2) Central Plateau, (3) 678 Northern Alps, (4) Central Western Alps, (5) Central Eastern Alps and (6) Southern 679 Alps. 680   681 
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Table 8. Statistically significant risk factors for seropositivity against any serovar and 682 against serovars Australis, Bratislava and Grippotyphosa at a MAT cut-off ≥ 1:100 683 tested in multivariable logistic regression models. Associations were considered 684 significant if p<0.05. The Akaike information criterion (AIC) is used to indicate the 685 relative quality of the used model. 686  Covariate Levels Odds ratio 95% CI p-value Risk factors for seropositivity against any serovar at MAT cut-off ≥ 1:100& Days since vaccination  1.0011 0.9986-1.0034 0.39 Age (years)  1.25 1.09-1.43 0.0012* Days since vaccination*Age  0.9995 0.9991-0.9999 0.0077* Risk factors for seropositivity against serovar Australis at a MAT cut off ≥ 1:100Δ Castrated No Ref    Yes 1.98 1.08-3.74 0.030* Days since vaccination 0.9969 0.995- 0.998 0.0004* Risk factors for seropositivity against serovar Bratislava at a MAT cut-off ≥ 1:100♥ Dog 1.40 0.49-4.32 0.53 Cat 2.27 0.72-7.37 0.16 Dog and Cat 2.40 0.58-9.02 0.20 Livestock +/-Dog/cat  4.21 0.20-34.77 0.23 Horses +/- Dog/cat 4.68 1.23-17.19 0.019* Risk factors for seropositivity against serovar Grippotyphosa at a MAT cut-off ≥ 1:100# Hunting  8.03 1.64-30.82 0.004*  687 & AIC full model = 361.64 & n=319, AIC final model = 382.36 & n=347. 688 Δ AIC full & final model = 296.83 & n=367 689 ♥AIC full model = 218.26 & n=342, AIC final model = 217.87, n=342 690 #AIC full & final model = 126.74 & n=337. 691  692   693 
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Supplemental Tables  694 Supplemental Table 1. Effect of stabilisier AssayAssure® on detection of leptospires 695 in canine urine samples during simulated shipping at room temperature. Fresh voided 696 urine from dogs were collected via free catch, pooled, and spiked with Leptospira 697 interrogans serovar Autumnalis at 1x104/ml, 1x103 and 1x102/ml. AssayAssure® was 698 added to the test group at a concentration of 1:11 according to the manufacturer’s 699 instructions. The spiked samples were incubated at room temperature for 4, 24 or 48 700 hours and then processed for DNA extraction and real time PCR. At 48h the target 701 gene lipl32 could only be amplified from urine samples with AssayAssure®, but not 702 from control samples. 703  704  705 Leptospires/ml urine  Mean Ct valuea Incubation time Control AssayAssure® 1x104  4h 32.303 31.244 1x104  24h 33.805 32.496 1x104  48h - 32.781 1x103  4h 34.728 34.728 1x103  24h 36.877 35.006 1x103  48h - 35.635 1x102  4h 39.047 37.921 1x102  24h 41.116 40.48 1x102  48h - 39.63  706 a Mean cycle number at which the fluorescence passes the threshold707 
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 Supplemental Table 2.  Prevalence of anti-lepto
spiral serum antibodies by sex, gender, neuter s
tatus, vaccination status, region and lifestyle. 
708 Prevalence is reported with 95% Confiden
ce Intervals (between brackets). 
709  710 Variable n MAT ≥1:40 
MAT≥1:100 AUS≥1:100 BRA≥1:10
0 GRI≥1:100 CAN≥1:100 
COP≥1:100 
All samples 377 55.7% (51.2
-60.7) 24.9% (20.7-29.4) 14.9% (11.4-18.6) 
8.8% (6.1-11.7) 4.5% (2.7-6.9) 5% (2.9-7
.2) 6.1% (4-8.5) 
Vaccinated No 84 42.7% (32.9
-53.7) 17.1% (9.2-26.8) 9.8% (3.7-17.1) 
8.5% (2.4-14.6) 2.4% (0.0-6.1) 3.7% (0.0
-8.5%) 3.7% (0.0-8.5%) 
Yes 289 59.2% (53.3-64.
7) 27% (22.1-32.2) 16.6% (12.5-21.1) 9%
 (5.9-12.5) 4.8% (2.4-7.3) 5.5% (3.1-8.
3) 6.6% (3.8-9.3) 
Sex Female 170 55.3% (47.7
-62.9) 25.9% (19.4-32.9) 17.1% (11.8-23.5) 
8.2% (4.1-12.4) 2.9% (0.6-5.9) 5.3% (2.4
-8.8) 5.9% (2.9-9.4) 
Male 199 55.3% (48.7-62.
3) 24.1% (18.1-30.2) 13.6% (9-18.6) 9.5
% (6-14.1) 5.5% (2.5-8.5) 5% (2-8)  
6% (3-9.5) 
Castrated No 168 52.4% (44.6
-59.5) 19% (13.1-25) 10.7% (6.5-16.1) 
11.3% (7.1-16.7) 3.6% (1.2-6.5) 4.8% (1.8
-8.3) 4.8% (1.8-7.7) 
Yes 200 57.5% (51-64.5)
 29.5% (23-36.5) 18.5% (13.5-23.5) 10.
5% (6.5-15) 5% (2.5-8.5) 5.5% (2.5-9)
 7% (4-20.5) 
Other animals No 107 55.1% (45.8
-64.5) 21.5% (14-29.9) 13.1% (7.5-20.6) 
5.6% (1.9-11.2) 5.6% (1.9-10.3) 3.7% (0.9
-7.5) 4.7% (0.9-9.3) 
Dog 117 50.4% (41.9-59.
8) 23.9% (16.2-31.6) 16.2% (10.3-23.1) 7.7
% (3.4-12.8) 5.1% (1.7-9.4) 6% (2.6-11.1
) 6.8% (2.6-12) 
Cat 59 66.1% (54.2-78)
 32.2% (20.3-45.8) 16.9% (8.5-27.1) 11.
9% (5.1-20.3) 3.4% (0.0-8.5) 10.2% (3.4-1
8.6) 11.9% (5.1-22) 
Dog and Cat 32 68.8% (53-84.4)
 25% (12.5-40.6) 21.9% (9.4-37.4) 12.
5% (3.1-25) 3.1% (0-9.4) 0%  
3.1% (0-9.4) 
Livestock +/-Dog/cat  5 60% (20-100) 
40% (0-80) 20% (0-60) 20% (0-6
0) 0% 20% (0-60) 
20% (0-60) 
Horses +/- Dog/cat 23 47.8% (26.1-69.
6) 34.8% (17.4-56.5) 8.7% (0-21.7) 21.
7% (4.5-39.1) 0% 4.3% (0-13) 
8.7%(0-21.7) 
Bioregion Jura 51 52% (37.3-6
4.7) 27.5% (15.7-39.2) 13.7% (3.9-23.5) 
13.7% (3.9-23.5) 5.9% (0-13.7) 3.9% (0-9
.8) 3.9% (0-9.8) 
Central Plateau 230 59.1% (53-64.8)
 25.2% (19.1-30.9) 14.8% (10-19.6) 8.3
% (4.8-11.7) 3.9% (1.7-6.5) 4.8% (2.2-7.
8) 6.5% (3.9-10) 
Northern Alps 66 56.1% (43.9-68.
2) 28.8% (18.2-39.4) 19.7% (10.6-28.8) 9.1
%(3-16.7) 6.1% (1.5-12.1) 6.1% (1.5-12
.1) 7.6% (1.5-15.2) 
Central western Alps 15 33.3% (13.3-60)
 6.7% (0-20) 6.7% (0-20) 0% 
 0% 6.7% (0-20) 
6.7% (0-20) 
Central Eastern Alps 5 80% (40-100) 
20% (0-60) 20% (0-60) 20% (0-6
0) 20% (0-60) 20% (0-60) 
20% (0-60) 
Southern Alps 10 20% (0-50) 
10% (0-30) 0% 0% 
0% 10% (0-30) 0% 
Surrounding  Shelter 21 47.6% (23.8
-66.7) 19% (4.8-38.1) 9.5% (0-23.8) 
4.8% (0-14.3) 0% 4.8% (0-1
4.3) 9.5% (0-23.8) 
Urban 49 60.4% (45.8-75)
 20.8% (10.4-33.3) 10.4% (2.1-18.8) 8.3
% (2.1-16.7) 0% 4.2% (0-10.4
) 4.2% (0-10.4) 
Rural 98 65.3% (56.1-74.
5) 28.6% (20.4-37.8) 19.4% (12.2-27.5) 9.2
% (4.1-15.3) 6.1% (2-11.2) 6.1% (2-11.2
) 6.1% (2-11.2) 
Farm 61 50.8% (39.3-63.
9) 26.2% (16.4-37.7) 16.4% (8.2-26.2) 9.8
% (3.3-18) 4.9% (0-11.5) 3.3% (0-8.2 
6.6% (1.6-13.1) 
Urban + Garden 27 44.4% (25.9-63)
 29.6% (14.8-48.1) 11.1% (0-25.9) 14.
8% (3.7-29.6) 3.7% (0-11.1) 11.1% (0-22
.2) 7.4% (18.5) 
Rural + Garden 105 52.4% (43.8-62.
9) 23.8% (16.2-32.4) 15.2% (8.6-21.9) 8.6
% (3.8-14.3) 5.7% (1.9-10.5) 4.8% (1-9.5)
 5.7% (1.9-10.5) 
Contact to acutely ill animals 
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 No 162 56.8% (48.8-64.2) 
24.1% (17.9-31.5) 14.2% (9.3-20.4) 6.2% (3.1
-9.9) 4.3% (1.3-7.4) 4.9% (1.9-8.6) 
4.9% (1.9-8.6) 
Yes 28 85.7% (71.4-96.
4) 53.6% (35.7-71.4) 42.9% (25-60.7) 17.
9% (3.6-32.1) 7.1% (0-17.9) 14.3% (3.6-2
8.6) 14.3% (3.6-28.6) 
I do not know  148 51.4% (43.3
-59.5) 23% (16.2-29.7) 12.2% (6.8-17.6) 
11.5% (6.8-16.9) 4.7% (2-8.1) 4.7% (1.4
-8.8) 5.4% (2-9.5) 
Previously diagnosed and treated for leptospirosis No 330 56.1% (50.9
-61.5) 24.8% (20-29.4) 14.2% (10.6-17.6) 
8.5% (5.8-11.2) 4.5% (2.4-6.7) 5.5% (3-7
.9) 5.8% (3.3-8.2) 
Yes 8 87.5% (62.5-100
) 75% (50-100) 75% (50-100) 50%
 (12.5-87.5) 12.5% (0-37.5) 37.5% (12.5-7
5) 12.5% (0-37.5) 
Fever this past year (dog) No 305 57.4% (50.8
-63.6) 26.9% (21.5-32.6) 16.5% (12-21.5) 
9.5% (5.8-13.2) 4.1% (2.1-6.6) 5.8% (2.9
-9.1) 5.8% (2.9-9.1) 
Yes 33 80% (64-92) 
36% (20-56) 20% (4-36) 8% (0-20
) 16% (4-32) 8% (0-20) 
12% (0-28) 
Fever this past year (owner) No 270 58.6% (52.6
-65.6) 27.4% (21.9-34) 16.7% (12.1-21.9) 
9.3% (6-13.5) 6% (3.3-9.3) 6.5% (3.3
-9.8) 7.4% (4.2-11.2) 
Yes 63 63.3% (49-77.6%
) 28.6% (16.3-42.9) 16.3% (6.1-26.5) 8.2%
 (2-16.3)  2% (0-6.1) 4.1% (2-16.3) 
2% (0-6.1) 
Outside <50% of time 259 57.1% (42.9
-67.9) 28.6% (17.9-41.1) 7.1% (1.8-14.3) 
10.7% (3.6-17.9) 7.1% (1.8-14.3) 5.4% (0-1
2.5) 8.9% (1.8-6.1) 
>50% of time 83 56.8% (50.6-62.
5) 24.7% (19.3-29.7) 16.6% (12.4-20.8) 8.5
% (5.4-12) 4.2% (1.9-6.9) 5% (2.7-7.7)
 4.6% (2.3-7.3) 
Walks in the Forest   
   
   
No 31 41.9% (25.8-61.
2) 19.4% (25.8-61.2) 16% (3.2-29) 6.5
% (0-16) 0% 3.2% (0-9.7)
 6.5% (0-16.1) 
Yes 307 58.3% (53.1-64.
2) 26.7% (21.5-32.2) 15.6% (11.4-19.9) 9.8
% (6.8-13) 5.2% (2.6-7.8) 5.9% (3.6-8.
5) 5.9% (3.6-8.5) 
Drinking from puddles/rivers No 104 57.7% (48.1
-67.3) 27.9% (19.2-36.5) 18.3% (10.6-26) 
7.7% (2.9-12.5) 2.9% (0-6.7) 3.8% (1-7
.7) 5.8% (1.9-10.6) 
Yes 233 56.7% (50.2-63.
1) 25.3% (19.7-30.9) 14.6% (10.3-19.3) 10.
3% (6.4-14.2) 5.6% (3-9) 6.4% (3.4-9.
9) 6% (3-9.4) 
Contacts with wild animals No 190 54.2% (46.8
-61.1) 25.8% (19.5-32.6) 17.4% (12.1-23.2) 
9.5% (5.3-14.2) 4.7% (1.6-8.4) 7.4% (3.7
-11.6) 6.3% (3.2-10) 
Yes 94 57.4% (47.9-67)
 23.4% (14.9-31.9) 12.8% (6.4-19.1) 7.4
% (3.2-12.8) 4.3% (0-8.5) 4.3% (1.1-8.
5) 4.3% (1.1-8.5) 
I do not know  54 64.8% (50-77.8)
 31.5% (20.4-44.4) 14.8% (5.6-24.1) 13%
 (3.8-22.2) 5.6% (0-13) 1.9% (0-5.6) 
7.4% (1.9-14.8) 
Swimming No 110 51.8% (42.7
-60.9) 28.2% (20-36.4) 18.2% (10.9-26.4) 
9.1% (4.5-14.5) 3.6% (0.9-7.3) 4.5% (0.9
-9.1) 3.6% (0.9-7.3) 
Yes 226 59.7% (53.5-65.
9) 25.2 (19.9-31) 14.6% (10.6-19.5) 9.7
% (6.2-13.7) 5.3% (2.7-8.4) 6.2% (3.5-9.
3) 7.1% (4-10.6) 
Hunting No 326 56.4% (50.6
-61.3) 25.8% (21.2-30.7) 15.6% (12-19.6) 
9.5% (6.1-12.9) 4% (1.8-6.1) 5.5% (3.1
-8) 6.1% (3.7-8.9%) 
Yes 12 66.7% (41.7-91.
7) 33.3% (8.3-58.3) 16.7% (0-41.7) 8.3
% (0-25) 25% (0-50) 8.3% (0-25) 
33% (8.3-58.3) 
Season of testing Spring 102 48% (38.2-5
7.8) 26.5% (18.6-36.3) 11.8% (5.9-17.6) 
7.8% (2.9-12.7) 3.9% (1-7.8) 5.9% (2-1
0.8) 4.9% (1-9.8) 
Sommer 98 60.2% (51-70.4)
 23.5% (15.3-32.6) 15.3% (8.2-22.4) 9.2
% (4.1-15.3) 3.1% (0-7.1) 3.1% (0-7.1)
 8.2% (3.1-14.3) 
Fall 167 57.5% (49.7-65.
3) 25.7% (19.8-32.3) 17.4% (12-23.4) 9.6
% (5.4-14.4) 6% (3-10.2) 6% (2.4-9.6)
 5.4% (1.8-9) 
Winter 7 42.9% (0-71.4) 
14.3% (0-42.9) 0% 0% 
0% 14.3% (0-42.9) 14.3% (0-
42.9) 
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 Supplemental Table 3. Number of individuals
, relative prevalence and 95% C.I. per Leptos
pira serovar for dogs vaccinated with a 
712 bivalent vaccine (n=43). Tested serovar
s: Australis (AUS), Autumnalis (AUT), Ballum (B
AL), Bratislava (BRA), Canicola (CAN), Copenha
geni 
713 (COP), Grippotyphosa (GRI), Hardjo (HAR
), Icterohaemorrhagie (ICT), Pomona (POM), Py
rogenes (PYR) and Tarassovi (TAR). 
714  715 MAT Titer  AUS BRA 
COP CAN GRI ICT POM
 PYR TAR AUT BAL 
HAR 
1:20 n 9 1 5 
8 - 3 2 3 
1 4 4 1 
% 20.9 2.3 11.6 18.6 
- 7 4.7 7 2.3 
9.3 9.3 2.3 
C.I. 9.3-32.6 0-7 4.7-20.9 7-30.2
 - 0-14 0-11.6 0-16.3 
0-7 2.3-18.6 2.3-18.6 0-7 
1:40 n 6 3 6 
9 1 5 2 - 
- 3 1 - 
% 14 7 14 20.9 
2.3 11.6 4.7 - - 
7 2.3 - 
C.I. 4.7-25.6 0-14 4.7-25.6 9.3-34.9
 0-7 2.3-20.9 0-11.6 - 
- 0-16.3 0-7 - 
1:100 n 1 - 1 
1 1 1 - - 
- - - - 
% 2.3 - 2.3 2.3 
2.3 2.3 - - - 
- - - 
C.I. 0-7 - 0-7 0-7 
0-7 0-7 - - - 
- - - 
1:200 n - - 3 
2 1 1 - 1 
- 1 - - 
% - - 7 4.7 
2.3 2.3 - 2.3 - 
2.3 - - 
C.I. - - 0-16.3 0-11.6
 0-7 0-7 - 0-7 
- 0-7 - - 
1:400 n 1 1 - 
- - - - - 
- - - - 
% 2.3 2.3 - - 
- - - - - 
- - - 
C.I. 0-7 0-7 - - 
- - - - - 
- - - 
1:800 n - - - 
- - - - - 
- - - - 
% - - - - 
- - - - - 
- - - 
C.I. - - - - 
- - - - - 
- - - 
1:1600 n 1 1 - 
- - - - - 
- - - - 
% 2.3 2.3 - - 
- - - - - 
- - - 
C.I. 0-7 0-7 - - 
- - - - - 
- - - 
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38 
 Supplemental Table 4. Number of individuals
, relative prevalence and 95% C.I. per Leptos
pira serovar for dogs vaccinated with a 
718 quadrivalent vaccine (n=246). Tested se
rovars: Australis (AUS), Autumnalis (AUT), Ballu
m (BAL), Bratislava (BRA), Canicola (CAN), 
719 Copenhageni (COP), Grippotyphosa (GR
I), Hardjo (HAR), Icterohaemorrhagie (ICT), Pom
ona (POM), Pyrogenes (PYR) and Tarassovi (TA
R). 
720  721 MAT Titer  AUS BRA
 COP CAN GRI ICT 
POM PYR TAR AUT BA
L HAR 
1:20 n 74 16 31 
58.56 15 21 23 6
 3 26 33 - 
% 30.1 6.5 12.6 22.8 
6.1 8.5 9.3 2.4 1.2
 10.6 13.4 - 
C.I. 24.8-36.2 3.7-9.8 8.5-16.7 17.9-28
 3.3-9.3 5.3-12.2 5.7-13 0.8-4.5 
0-2.8 6.9-14.6 9.3-17.9 - 
1:40 n 53 14 33 
57 23 20 18 4 
- 9 1 - 
% 21.5 5.7 13.4 23.2 
9.3 8.1 7.3 1.6 - 
3.7 0.4 - 
C.I. 16.7-26.8 2.9-8.9 9.3-17.9 17.9-2
 5.7-13 4.9-11.8 4.1-11 0.4-3.3 
- 1.6-6.1 0-1.2 - 
1:100 n 30 11 9 
9 7 2 8 1 
1 5 - - 
% 12.2 4.5 3.7 3.7 
2.8 0.8 3.3 0.4 0.4
 2 - - 
C.I. 8.5-16.3 2-6.9 1.6-6.1 1.2-6.1
 0.8-4.9 0-2 1.2-5.7 0-1.2 
0-1.2 0.4-1 - - 
1:200 n 8 6 3 
4 4 1 4 1 
- - - - 
% 3.3 2.4 1.2 1.6 
1.6 0.4 1.6 0.4 - 
- - - 
C.I. 1.2-5.7 0.8-4.5 0-2.8 0.4-3.3
 0.4-3.3 0-1.2 0.4-3.3 0-1.2 
- - - - 
1:400 n 3 4 3 
- - 1 - - 
- 2 - - 
% 1.2 1.6 1.2 - 
- 0.4 - - - 
0.8 - - 
C.I. 0-2.8 0.4-3.3 0-2.8 - 
- 0-1.2 - - - 
0-2 - - 
1:800 n 1 3 - 
- 1 - 1 - 
- - - - 
% 0.4 1.2 - - 
0.4 - 0.4 - - 
- - - 
C.I. 0-1.2 0-2.8 - - 
0-1.2 - 0-1.2 - -
 - - - 
1:1600 n 2 - - 
- - - - - 
- - - - 
% 0.8 - - - 
- - - - - 
- - - 
C.I. 0-2 - - - 
- - - - - 
- - - 
1:3200 n 1 - - 
- - - - - 
- - - - 
% 0.4 - - - 
- - - - - 
- - - 
C.I. 0-1.2 - - - 
- - - - - 
- - -  
722  723   724 
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Figure legends  725 Figure 1. Biogeographic regions of Switzerland. The six biogeographic regions of 726 Switzerland and the number of MAT seropositive dogs per total tested at a cut-off ≥ 727 1:40 and ≥ 1:100 are shown. 728  729 Figure 2. Graphical overview of stdy population and statistical analyses MAT: 730 Microscopic agglutination test; RT-PCR: LipL32 real time PCR 731 AUS: Australis; CAN: Canicola, GRI: Grippotyphosa, ICT: Icterohaemorrhagie   732  733 Figure 3. The geographical distribution of 377 dogs tested for serum antibodies 734 against Leptospira spp via MAT. Geocoding was performed based on the zip code 735 of the owner’s home address. Seropositivity was defined as positive MAT titre at 736 ≥1:100.  737  738 Figure 4 Relative prevalence (%) of anti-leptospiral serum antibodies overall 739 and per Leptospira serovar at reciprocal titres of ≥1:40 and ≥1:100.  740 Tested serovars: Australis (AUS), Autumnalis (AUT), Ballum (BAL), Bratislava (BRA), 741 Canicola (CAN), Copenhageni (COP), Grippotyphosa (GRI), Hardjo (HAR), 742 Icterohaemorrhagie (ICT), Pomona (POM), Pyrogenes (PYR) and Tarassovi (TAR). 743  744 Supplemental Figure 1: Questionnaire filled in by the owners of dogs enrolled in the 745 study.  746  747  748 Supplemental Figure 2. The 26 cantons of Switzerland and their corresponding 749 number of seropositive dogs per total tested at a cut-off of MAT≥1:40 and 750 MAT≥1:100.  751 
40   
 752 Legend to suppl Figure 2 753 AG Aargau NW Nidwalden AR Appenzell Ausserrhoden OW Obwalden AI Appenzell Innerrhoden SG Sankt Gallen BL Basel-Land SH Schaffhausen BS Basel-Stadt SZ Schwyz BE Bern SO Solothurn FR Fribourg TG Thurgau GE Genève TI Ticino GL Glarus UR Uri GR Graubünden VS Valais JU Jura VD Vaud LU Luzern ZG Zug NE Neuchâtel ZH Zürich  754   755 
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 Group  n MAT ≥40 % (95% CI) MAT ≥100 % (95% CI) Overall population 377 55.7% (51-60.7) 24.9% ( 20.7-39.4)    Not vaccinated 84 42.7% (32.9-53.7) 17.2% (10-27)    Vaccinated > 16 weeks ago 335 49% (43.6-54) 20.6% (16.4-25.1)       Bi-valent vaccine 42         Quadrivalent vaccine 246      Vaccinated < 16 weeks ago 42    Kommentar [SS(1]: Numbers don’t add up 
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